Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer

Clinical trial NCT02174887 · COMPLETED

Trial details

NCT number: NCT02174887
Sponsor: Institut Paoli-Calmettes
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2014-09-01
Primary completion: 2016-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.